Clinical Publications

The PRESERVE Study

A Pivotal Study of the NanoKnife System for Ablation of Prostate Tissue in an Intermediate-Risk Patient Population.

Learn More

The DIRECT Study

A Clinical Study That Evaluates the Effects of Irreversible Electroporation (IRE) Ablation Technology on the Treatment of Patients with Stage III Pancreatic Cancer.

Learn More

Physicians
Research
Physician Locator
Resources
Risk Information
Get in Touch
Privacy Statement
Terms of Use

AngioDynamics, the AngioDynamics logo, NanoKnife, and the NanoKnife logo are trademarks and/or registered trademarks of AngioDynamics, Inc., an affiliate or subsidiary.

Having trouble using this site? Accessibility is our goal, please contact us with site improvements. Sitemap

GL/ON/WP/3160 Rev 01 01/2025